Latest News

Climb Bio (NASDAQ:CLYM) outlined its clinical development strategy and upcoming data readouts during a fireside chat at H.C. Wainwright’s BioConnect Conference, with management emphasizing two biologic drug programs aimed at immune-mediated diseases, including nephrology and hematology indications.

Nvidia now sees sales growing an astounding 95% in the current quarter, and that's without any China sales.

Charter Communications (NASDAQ:CHTR) Chief Financial Officer Jessica Fischer said the company’s top priority remains growing its connectivity business while it works through major investment initiatives, prepares for the integration of Cox assets and seeks to improve free cash flow as capital spendi

Anthropic is reportedly nearing its first quarterly profit as revenue tops $10 billion amid booming demand for Claude AI.

A group touting itself as a "nonpartisan" prediction market watchdog launched an ad campaign targeting Kalshi on Wednesday, May 20, calling for greater accountability in how the platform operates.

Chris Christie blasted President Donald Trump over rising living costs and foreign policy priorities as polls show worsening voter sentiment ahead of the midterms.

If you are looking for a GLP-1 investment, you can buy the leader, the underdog, or the upstart.

Trump says Cuba is falling apart as Rick Scott calls for regime collapse after Raúl Castro murder charges, escalating U.S.-Cuba tensions and political pressure.

U Power Ltd. shares jumped in after-hours trading following insider purchases and multiple SEC filings by company executives.